MaxCyte Announces CEO Transition and Updates Revenue Guidance for 2023

Doug Doerfler, President and CEO, to Retire Effective December 31, 2023; will continue to serve as an advisor to MaxCyte Maher Masoud, EVP, Head of Global Business Development and Chief Counsel,...

Related Keywords

United Kingdom ,Chris Welsh ,Mary Jane Elliott ,David Deuchler ,Panmure Gordon ,Emma Earl Freddy Crossley ,Doug Doerfler ,Maher Masoud ,Richard Douglas ,Rupert Dearden ,Glen Research ,Michigan State University College Of Law ,Maxcyte Inc ,Nasdaq ,Head Of Global Business Development ,Human Genome Sciences ,Exchange Commission ,Linkedin ,Twitter ,University Of Maryland ,Exchange Commission On ,Glaxosmithkline ,Gilmartin Group ,Retire Effective December ,Global Business Development ,Chief Counsel ,Effective January ,Chief Executive Officer ,Strategic Platform ,Corporate Counsel ,Juris Doctor ,Michigan State University College ,Flow Electroporation ,Private Securities Litigation Reform Act ,Annual Report ,Investor Menu ,Cyte Contacts ,Joint Corporate ,Freddy Crossley ,Markets ,